Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosis as an Attractive Theranostic Outlook for Tackling Non-Small Lung Cancer: A Mini Review
Source abstract
Abstract
Lung cancer is a highly aggressive neoplasm that is now a leading cause of cancer death worldwide. One of the major approaches for killing cancer cells is related with activation of apoptotic cell death with anti-cancer drugs. However, the efficiency of apoptosis induction in tumors is limited. Consequently, the development of other forms of non-apoptotic cell death is up to date challenge for scientists worldwide. This situation motivated us to define the aim of this mini-review: gathering knowledge regarding ferroptosis—newly defined programmed cell death process characterized by the excessive accumulation of iron—and combining it with yet another interesting nanomaterial-based graphene approach. In this manuscript, we presented brief information about non-small lung cancer and ferroptosis, followed by a section depicting the key-features of graphene-based nanomaterials influencing their biologically relevant properties.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · MXene and MAX Phase Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Histology and Embryology, Medical University in Bialystok, Waszyngtona 13, 15-269 Białystok, Poland
Graphene and Composites Research Group, Łukasiewicz Research Network—Institute of Microelectronics and Photonics, al. Lotników 32/46, 02-668 Warszawa, Poland
Funding
Łukasiewicz Research Network—Institute of Microelectronics and Photonics · Medical University in Bialystok
References (71)
Show source-provided references
1. Genetic Alterations Defining NSCLC Subtypes and Their Therapeutic Implications10.1016/j.lungcan.2013.07.025 ↗
2. Global Epidemiology of Lung Cancer10.5334/aogh.2419 ↗
3. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 201210.1002/ijc.29210 ↗
4. Lung Cancer Epidemiology in Korea10.4143/crt.2016.178 ↗
5. Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?10.3389/fonc.2018.00267 ↗
6. The Impact of Systemic Treatment on Brain Metastasis in Patients with Non-Small-Cell Lung Cancer: A Retrospective Nationwide Population-Based Cohort Study10.1038/s41598-019-55150-6 ↗
7. Therapeutic Management Options for Stage III Non-Small Cell Lung Cancer10.5306/wjco.v8.i1.1 ↗
8. Adjuvant Cisplatin-Based Chemotherapy for Resected NSCLC: One Size Fits All?10.1097/CAD.0b013e32833dbbfe ↗
9. Personalized Medicine in Non-Small Cell Lung Cancer: A Review from a Pharmacogenomics Perspective10.1016/j.apsb.2018.04.005 ↗
10. Cancer Drug Resistance: An Evolving Paradigm10.1038/nrc3599 ↗
11. Role of Wnt/β-Catenin Pathway in Inducing Autophagy and Apoptosis in Multiple Myeloma Cells10.3892/ol.2016.5289 ↗
12. Three-Dimensional Electrochemical DNA Biosensor Based on 3D Graphene-Ag Nanoparticles for Sensitive Detection of CYFRA21-1 in Non-Small Cell Lung Cancer10.1016/j.snb.2017.09.111 ↗
13. Adsorption of Cisplatin on Oxidized Graphene Nanoribbons for Improving the Uptake in Non-Small Cell Lung Carcinoma Cell Line A549
14. Well-Defined Graphene Oxide as a Potential Component in Lung Cancer Therapy10.2174/1568009619666191021113807 ↗
15. Molecular Mechanisms of Ferroptosis and Its Role in Cancer Therapy10.1111/jcmm.14511 ↗
16. Induction and Application of Ferroptosis in Cancer Therapy10.1186/s12935-021-02366-0 ↗
17. Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases10.3389/fnins.2020.00267 ↗
18. SLC7A11 Regulated by NRF2 Modulates Esophageal Squamous Cell Carcinoma Radiosensitivity by Inhibiting Ferroptosis10.1186/s12967-021-03042-7 ↗
19. Broad Targeting of Resistance to Apoptosis in Cancer10.1016/j.semcancer.2015.03.001 ↗
20. Erastin/Sorafenib Induces Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Ferroptosis through Inhibition of the Nrf2/XCT Pathway
21. (2022, January 25). BioRender. Available online: https://biorender.com/.
22. Molecular Mechanisms of Ferroptosis and Its Role in Pulmonary Disease10.1155/2020/9547127 ↗
23. Metabolic Networks in Ferroptosis (Review)
24. Modulations of Ferroptosis in Lung Cancer Therapy10.1080/14728222.2022.2032651 ↗
25. Investigation into Morphological and Electromechanical Surface Properties of Reduced-Graphene-Oxide-Loaded Composite Fibers for Bone Tissue Engineering Applications: A Comprehensive Nanoscale Study Using Atomic Force Microscopy Approach10.1016/j.micron.2021.103072 ↗
26. Chlanda, A., Kowiorski, K., Małek, M., Kijeńska-Gawrońska, E., Bil, M., Djas, M., Strachowski, T., Swieszkowski, W., and Lipińska, L. (2021). Morphology and Chemical Purity of Water Suspension of Graphene Oxide FLAKES Aged for 14 Months in Ambient Conditions. A Preliminary Study. Materials, 14.10.3390/ma14154108 ↗
27. Induction of Ferroptosis in Response to Graphene Quantum Dots through Mitochondrial Oxidative Stress in Microglia10.1186/s12989-020-00363-1 ↗
28. Nitrogen-Doped Graphene Quantum Dots Induce Ferroptosis through Disrupting Calcium Homeostasis in Microglia10.1186/s12989-022-00464-z ↗
29. Dynamic Interactions and Intracellular Fate of Label-Free, Thin Graphene Oxide Sheets within Mammalian Cells: Role of Lateral Sheet Size10.1039/D1NA00133G ↗
30. Graphene-Based Antimicrobial Biomedical Surfaces10.1002/cphc.202000769 ↗
31. Mechano-Bactericidal Mechanism of Graphene Nanomaterials10.1098/rsfs.2017.0060 ↗
32. Electrospun Poly(3-Hexylthiophene)/Poly(Ethylene Oxide)/Graphene Oxide Composite Nanofibers: Effects of Graphene Oxide Reduction10.1002/pat.3816 ↗
33. Synergistic Effects of Reduced Graphene Oxide and Hydroxyapatite on Osteogenic Differentiation of MC3T3-E1 Preosteoblasts10.1016/j.carbon.2015.09.028 ↗
34. Bebber, C.M., Müller, F., Clemente, L.P., Weber, J., and von Karstedt, S. (2020). Ferroptosis in Cancer Cell Biology. Cancers, 12.10.3390/cancers12010164 ↗
35. Superparamagnetic Iron Oxide Nanoparticles: Amplifying Ros Stress to Improve Anticancer Drug Efficacy10.7150/thno.5411 ↗
36. Bonsai-Inspired AIE Nanohybrid Photosensitizer Based on Vermiculite Nanosheets for Ferroptosis-Assisted Oxygen Self-Sufficient Photodynamic Cancer Therapy10.1016/j.nantod.2022.101477 ↗
37. Microenvironment-Driven Sequential Ferroptosis, Photodynamic Therapy, and Chemotherapy for Targeted Breast Cancer Therapy by a Cancer-Cell-Membrane-Coated Nanoscale Metal-Organic Framework10.1016/j.biomaterials.2022.121449 ↗
38. Glycyrrhetinic Acid Nanoparticles Combined with Ferrotherapy for Improved Cancer Immunotherapy10.1016/j.actbio.2022.03.030 ↗
39. Ultrasound-Augmented Nanocatalytic Ferroptosis Reverses Chemotherapeutic Resistance and Induces Synergistic Tumor Nanotherapy10.1002/adfm.202107529 ↗
40. Zinc Oxide Nanosphere for Hydrogen Sulfide Scavenging and Ferroptosis of Colorectal Cancer10.1186/s12951-021-01069-y ↗
41. Ferroptosis/Pyroptosis Dual-Inductive Combinational Anti-Cancer Therapy Achieved by Transferrin Decorated NanoMOF10.1039/D0NH00674B ↗
42. An Innovative NRF2 Nano-Modulator Induces Lung Cancer Ferroptosis and Elicits an Immunostimulatory Tumor Microenvironment10.7150/thno.57803 ↗
43. Fe(II) and Tannic Acid-Cloaked MOF as Carrier of Artemisinin for Supply of Ferrous Ions to Enhance Treatment of Triple-Negative Breast Cancer10.1186/s11671-021-03497-z ↗
44. Targeted Manganese Doped Silica Nano GSH-Cleaner for Treatment of Liver Cancer by Destroying the Intracellular Redox Homeostasis10.7150/thno.46771 ↗
45. Mitochondrial Membrane Anchored Photosensitive Nano-Device for Lipid Hydroperoxides Burst and Inducing Ferroptosis to Surmount Therapy-Resistant Cancer10.7150/thno.36283 ↗
46. Graphene Oxide Modulates Inter-Particle Interactions in 3D Printable Soft Nanocomposite Hydrogels Restoring Magnetic Hyperthermia Responses10.1016/j.jcis.2021.12.048 ↗
47. Nasiłowska, B., Bogdanowicz, Z., Hińcza, K., Mierczyk, Z., Góźdź, S., Djas, M., Kowiorski, K., Bombalska, A., and Kowalik, A. (2020). Graphene Oxide Aerosol Deposition and Its Influence on Cancer Cells. Preliminary Results. Materials, 13.10.3390/ma13194464 ↗
48. (2022, May 05). EP 2778128 B1 20160302—Method of Thermal Reduction of Graphene OXIDE. Available online: https://data.epo.org/gpi/EP2778128B1-METHOD-OF-THERMAL-REDUCTION-OF-GRAPHENE-OXIDE.
49. (2022, May 05). EP 2653445 B1 20171011—The Method of Graphene Oxide Chemical Reduction. Available online: https://data.epo.org/gpi/EP2653445B1-The-method-of-graphene-oxide-chemical-reduction.
50. Toxicology Data of Graphene-Family Nanomaterials: An Update10.1007/s00204-020-02717-2 ↗
51. The Toxicity of Graphene Quantum Dots10.1039/C6RA16516H ↗
52. Physico-Chemical Properties Based Differential Toxicity of Graphene Oxide/Reduced Graphene Oxide in Human Lung Cells Mediated through Oxidative Stress10.1038/srep39548 ↗
53. An Assessment of the Cytotoxic Effects of Graphene Nanoparticles on the Epithelial Cells of the Human Lung10.1177/0748233718817180 ↗
54. Jagiełło, J., Chlanda, A., Baran, M., Gwiazda, M., and Lipińska, L. (2020). Synthesis and Characterization of Graphene Oxide and Reduced Graphene Oxide Composites with Inorganic Nanoparticles for Biomedical Applications. Nanomaterials, 10.10.3390/nano10091846 ↗
55. Graphene Oxide Nanofilm to Functionalize Bioinert High Strength Ceramics10.1016/j.apsusc.2021.150670 ↗
56. Biocompatibility Considerations in the Design of Graphene Biomedical Materials10.1002/admi.201900229 ↗
57. Antibacterial Activity of Graphite, Graphite Oxide, Graphene Oxide, and Reduced Graphene Oxide: Membrane and Oxidative Stress10.1021/nn202451x ↗
58. Jagiełło, J., Sekuła-Stryjewska, M., Noga, S., Adamczyk, E., Dźwigońska, M., Kurcz, M., Kurp, K., Winkowska-Struzik, M., Karnas, E., and Boruczkowski, D. (2019). Impact of Graphene-Based Surfaces on the Basic Biological Properties of Human Umbilical Cord Mesenchymal Stem Cells: Implications for Ex Vivo Cell Expansion Aimed at Tissue Repair. Int. J. Mol. Sci., 20.10.3390/ijms20184561 ↗
59. Characterization and Influence of Hydroxyapatite Nanopowders on Living Cells10.3762/bjnano.9.286 ↗
60. The Influence of Carbon-Encapsulated Iron Nanoparticles on Elastic Modulus of Living Human Mesenchymal Stem Cells Examined by Atomic Force Microscopy10.1016/j.micron.2018.02.006 ↗
61. Nanoparticle Delivery and Tumor Vascular Normalization: The Chicken or The Egg?10.3389/fonc.2019.01227 ↗
62. Cytotoxic Properties of Graphene Derivatives Depending on Origin and Type of Cell Line10.1557/jmr.2020.201 ↗
63. Graphene Oxide Selectively Targets Cancer Stem Cells, across Multiple Tumor Types: Implications for Non-Toxic Cancer Treatment, via “Differentiation-Based Nano-Therapy”10.18632/oncotarget.3348 ↗
64. Perini, G., Palmieri, V., Ciasca, G., De Spirito, M., and Papi, M. (2020). Unravelling the Potential of Graphene Quantum Dots in Biomedicine and Neuroscience. Int. J. Mol. Sci., 21.10.3390/ijms21103712 ↗
65. Deposition of Graphene Nanomaterial Aerosols in Human Upper Airways10.1080/15459624.2015.1076162 ↗
66. Toxicity of Graphene-Family Nanoparticles: A General Review of the Origins and Mechanisms10.1186/s12989-016-0168-y ↗
67. Graphene and the Immune System: A Romance of Many Dimensions10.3389/fimmu.2017.00673 ↗
68. Chronic Exposure to Graphene Oxide (GO) Induced Inflammation and Differentially Disturbed the Intestinal Microbiota in Zebrafish10.1039/C9EN00364A ↗
69. Graphene Oxide Nanoparticles Induce Apoptosis in Wild-Type and CRISPR/Cas9-IGF/IGFBP3 Knocked-out Osteosarcoma Cells10.7150/jca.46464 ↗
70. Distribution and Biocompatibility Studies of Graphene Oxide in Mice after Intravenous Administration10.1016/j.carbon.2010.11.005 ↗
71. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment10.1021/acsnano.8b04758 ↗